Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeoChord
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeoChord

NeoChord

Seed

NeoChord: Innovating heart-friendly mitral valve repair devices.

HQ
St. Louis Park, MN, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

NeoChord, founded with a mission to revolutionize cardiac surgery, focuses on developing innovative medical devices for mitral valve repair. Their flagship product, the NeoChord Artificial Chordae Delivery System, enables minimally invasive, echo-guided repair of the mitral valve on a beating heart, addressing mitral valve regurgitation. This approach aims to reduce the risks and recovery time associated with traditional open-heart surgery, providing a safer and more efficient treatment option for patients.

Key figures in NeoChord include experienced cardiologists and medical device experts who drive the company's innovation. The company has garnered attention from notable investors in the medical technology sector. NeoChord's achievements include successful clinical trials and widespread adoption of their system in leading cardiac centers globally. Their impact is significant, offering a transformative solution that improves patient outcomes and sets new standards in cardiac care.

NeoChord - Similar Companies

Cardiac Dimensions logo

Cardiac Dimensions

Nectero Medical logo

Nectero Medical

necteromed.com

Neocis logo

Neocis

Nico logo

Nico

niconeuro.com

Phoenix Cardiac logo

Phoenix Cardiac

Viacor logo

Viacor

NirvaMed logo

NirvaMed

MicroPort CardioFlow logo

MicroPort CardioFlow

Innerpulse logo

Innerpulse

CardioFocus logo

CardioFocus

cardiofocus.com

VisCardia logo

VisCardia

viscardia.com

Neocardial Technologies logo

Neocardial Technologies

neocardial.com

NeuraLace Medical logo

NeuraLace Medical

Endovention logo

Endovention

NeuRx Medical logo

NeuRx Medical

neurxmed.com

NeoChord - Quick Facts

Who are NeoChord's competitors?

Companies similar to NeoChord include Cardiac Dimensions, Nectero Medical, Neocis and Nico.

When was NeoChord founded?

NeoChord was founded in 2009.

Where is NeoChord's headquarters located?

NeoChord's headquarters is located in St. Louis Park, MN, US.

When was NeoChord's last funding round?

NeoChord's most recent funding round was for $2.8M (USD) in May 2021.

How much has NeoChord raised to-date?

As of May 6, 2021, NeoChord has raised a total of $89.9M (USD).

How many employees does NeoChord have?

NeoChord has 24 employees as of Feb 5, 2024.

NeoChord - Classification

Industry
  • Hardware
Ownership
  • Private Equity
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified